In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MetaCure Ushers in a New Era in Interventional Diabetes

Executive Summary

Welcome to the new world of interventional diabetes. Based on new data, institutions offering gastric bypass surgeries for weight loss are now recasting them as treatments for type 2 diabetes. This is a dramatic change in perspective within the drug-oriented diabetology world. Now MetaCure hopes to take that interventional notion a step further, with a minimally-invasive and reversible therapy based on electrical stimulation applied to the stomach.
Advertisement

Related Content

Neurostim Companies Defend Their Role in Obesity
Exploring the Bariatric Surgery/Diabetes Link: An Interview With Francesco Rubino, MD
A Mechanistic Look at Diabetes Surgery
GI Dynamics: In Metabolic Disease a Device Might Trump Drugs
The Other Diabetes: An Interventional Market Emerges
The Other Diabetes: An Interventional Market Emerges
Market & Industry Briefs

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003101

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel